Title : Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway.

Pub. Date : 2008 Jun 15

PMID : 18559577






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The identification of non-ATP-competitive inhibitors of the MAPK kinase MAPK/ERK kinase (MEK) resulted in the first demonstration that the ERK pathway could be effectively shut down in a highly selective fashion. Adenosine Triphosphate mitogen-activated protein kinase 1 Homo sapiens
2 The identification of non-ATP-competitive inhibitors of the MAPK kinase MAPK/ERK kinase (MEK) resulted in the first demonstration that the ERK pathway could be effectively shut down in a highly selective fashion. Adenosine Triphosphate mitogen-activated protein kinase 1 Homo sapiens
3 The identification of non-ATP-competitive inhibitors of the MAPK kinase MAPK/ERK kinase (MEK) resulted in the first demonstration that the ERK pathway could be effectively shut down in a highly selective fashion. Adenosine Triphosphate mitogen-activated protein kinase 1 Homo sapiens
4 The identification of non-ATP-competitive inhibitors of the MAPK kinase MAPK/ERK kinase (MEK) resulted in the first demonstration that the ERK pathway could be effectively shut down in a highly selective fashion. Adenosine Triphosphate mitogen-activated protein kinase 1 Homo sapiens